Stockreport

Did VK2735's VANQUISH-2 Enrollment Milestone Just Reframe Viking Therapeutics' (VKTX) Obesity Drug Ambitions? [Yahoo! Finance]

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
PDF evaluated over 78 weeks in about 1,000 adults with type 2 diabetes who are obese or overweight, with body-weight change as the primary endpoint. This milestone, combin [Read more]